221 related articles for article (PubMed ID: 15681480)
1. Sensitive detection of deletions of one or more exons in the neurofibromatosis type 2 (NF2) gene by multiplexed gene dosage polymerase chain reaction.
Diebold R; Bartelt-Kirbach B; Evans DG; Kaufmann D; Hanemann CO
J Mol Diagn; 2005 Feb; 7(1):97-104. PubMed ID: 15681480
[TBL] [Abstract][Full Text] [Related]
2. Mutation scanning of the NF2 gene: an improved service based on meta-PCR/sequencing, dosage analysis, and loss of heterozygosity analysis.
Wallace AJ; Watson CJ; Oward E; Evans DG; Elles RG
Genet Test; 2004; 8(4):368-80. PubMed ID: 15684865
[TBL] [Abstract][Full Text] [Related]
3. Detection of novel NF2 mutations by an RNA mismatch cleavage method.
Faudoa R; Xue Z; Lee F; Baser ME; Hung G
Hum Mutat; 2000; 15(5):474-8. PubMed ID: 10790209
[TBL] [Abstract][Full Text] [Related]
4. Large intragenic deletions of the NF2 gene: breakpoints and associated phenotypes.
Abo-Dalo B; Kutsche K; Mautner V; Kluwe L
Genes Chromosomes Cancer; 2010 Feb; 49(2):171-5. PubMed ID: 19924781
[TBL] [Abstract][Full Text] [Related]
5. Application of COLD-PCR for improved detection of NF2 mosaic mutations.
Paganini I; Mancini I; Baroncelli M; Arena G; Gensini F; Papi L; Sestini R
J Mol Diagn; 2014 Jul; 16(4):393-9. PubMed ID: 24815379
[TBL] [Abstract][Full Text] [Related]
6. Mutational analysis of the NF2 gene in sporadic meningiomas by denaturing high-performance liquid chromatography.
Kim JH; Kim IS; Kwon SY; Jang BC; Suh SI; Shin DH; Jeon CH; Son EI; Kim SP
Int J Mol Med; 2006 Jul; 18(1):27-32. PubMed ID: 16786152
[TBL] [Abstract][Full Text] [Related]
7. Screening for large mutations of the NF2 gene.
Kluwe L; Nygren AO; Errami A; Heinrich B; Matthies C; Tatagiba M; Mautner V
Genes Chromosomes Cancer; 2005 Apr; 42(4):384-91. PubMed ID: 15645494
[TBL] [Abstract][Full Text] [Related]
8. Detection of rearrangements in the NF2 gene using semi-quantitative multiplex fluorescent PCR.
Sestini R; Putignano AL; Ammannati F; Papi L
Genet Test; 2005; 9(1):14-9. PubMed ID: 15857181
[TBL] [Abstract][Full Text] [Related]
9. Impairment of cell adhesion by expression of the mutant neurofibromatosis type 2 (NF2) genes which lack exons in the ERM-homology domain.
Koga H; Araki N; Takeshima H; Nishi T; Hirota T; Kimura Y; Nakao M; Saya H
Oncogene; 1998 Aug; 17(7):801-10. PubMed ID: 9779996
[TBL] [Abstract][Full Text] [Related]
10. Determination of gene dosage by a quantitative adaptation of the polymerase chain reaction (gd-PCR): rapid detection of deletions and duplications of gene sequences.
Celi FS; Cohen MM; Antonarakis SE; Wertheimer E; Roth J; Shuldiner AR
Genomics; 1994 May; 21(2):304-10. PubMed ID: 8088823
[TBL] [Abstract][Full Text] [Related]
11. Severe phenotype of neurofibromatosis type 2 in a patient with a 7.4-MB constitutional deletion on chromosome 22: possible localization of a neurofibromatosis type 2 modifier gene?
Bruder CE; Ichimura K; Blennow E; Ikeuchi T; Yamaguchi T; Yuasa Y; Collins VP; Dumanski JP
Genes Chromosomes Cancer; 1999 Jun; 25(2):184-90. PubMed ID: 10338003
[TBL] [Abstract][Full Text] [Related]
12. Alport syndrome. Molecular genetic aspects.
Hertz JM
Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
[TBL] [Abstract][Full Text] [Related]
13. Mutational analysis of the nf2 tumour suppressor gene in three subtypes of primary human malignant mesotheliomas.
Schipper H; Papp T; Johnen G; Pemsel H; Bastrop R; Müller KM; Wiethege T; Jaworska M; Krismann M; Schiffmann D; Rahman Q
Int J Oncol; 2003 May; 22(5):1009-17. PubMed ID: 12684666
[TBL] [Abstract][Full Text] [Related]
14. [Development and establishment of a yeast-based stop codon assay for detection of NF2 gene premature-terminating mutations].
Kobayashi H
Hokkaido Igaku Zasshi; 1999 Sep; 74(5):377-86. PubMed ID: 10495852
[TBL] [Abstract][Full Text] [Related]
15. NF2 mutation screening by denaturing high-performance liquid chromatography and high-resolution melting analysis.
Sestini R; Provenzano A; Bacci C; Orlando C; Genuardi M; Papi L
Genet Test; 2008 Jun; 12(2):311-8. PubMed ID: 18554169
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization of germline NF2 gene rearrangements.
Legoix P; Sarkissian HD; Cazes L; Giraud S; Sor F; Rouleau GA; Lenoir G; Thomas G; Zucman-Rossi J
Genomics; 2000 Apr; 65(1):62-6. PubMed ID: 10777666
[TBL] [Abstract][Full Text] [Related]
17. The neurofibromatosis type 2 gene is mutated in perineurial cell tumors: a molecular genetic study of eight cases.
Lasota J; Fetsch JF; Wozniak A; Wasag B; Sciot R; Miettinen M
Am J Pathol; 2001 Apr; 158(4):1223-9. PubMed ID: 11290539
[TBL] [Abstract][Full Text] [Related]
18. The location of constitutional neurofibromatosis 2 (NF2) splice site mutations is associated with the severity of NF2.
Baser ME; Kuramoto L; Woods R; Joe H; Friedman JM; Wallace AJ; Ramsden RT; Olschwang S; Bijlsma E; Kalamarides M; Papi L; Kato R; Carroll J; Lázaro C; Joncourt F; Parry DM; Rouleau GA; Evans DG
J Med Genet; 2005 Jul; 42(7):540-6. PubMed ID: 15994874
[TBL] [Abstract][Full Text] [Related]
19. Identification of genetic aberrations on chromosome 22 outside the NF2 locus in schwannomatosis and neurofibromatosis type 2.
Buckley PG; Mantripragada KK; Díaz de Ståhl T; Piotrowski A; Hansson CM; Kiss H; Vetrie D; Ernberg IT; Nordenskjöld M; Bolund L; Sainio M; Rouleau GA; Niimura M; Wallace AJ; Evans DG; Grigelionis G; Menzel U; Dumanski JP
Hum Mutat; 2005 Dec; 26(6):540-9. PubMed ID: 16287142
[TBL] [Abstract][Full Text] [Related]
20. Characterisation of 16 polymorphic markers in the NF2 gene: application to hemizygosity detection.
Legoix P; Legrand MF; Ollagnon E; Lenoir G; Thomas G; Zucman-Rossi J
Hum Mutat; 1999; 13(4):290-3. PubMed ID: 10220142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]